investor
IP News

SCROLL DOWN
IP News
IP News.
’19 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING PROTEINOPATHIES COMPRISING SAME 2nd(KR, US, EP, JP, CN, TW)
Date
2021-06-10
View
266

’19 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING,

OR TREATING PROTEINOPATHIES COMPRISING SAME 2nd(KR, US, EP, JP, CN, TW)

 

The present invention relates to a novel p62 ligand compound, or a stereoisomer, solvate, hydrate, or prodrug thereof, and a pharmaceutical or
 food composition for preventing or treating proteopathies comprising same as an active ingredient.
The p62 ligand compound according to the present invention activates selective autophagy in cells,
thereby selectively removes proteins, organelles, and aggregates in the body,
and thus can be usefully employed as a pharmaceutical composition for preventing, alleviating, or treating various proteinopathies.